A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia. Issue 2 (23rd November 2020)

Record Type:: Journal Article
Title:: A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia. Issue 2 (23rd November 2020)
Main Title:: A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia
Authors:: Zheng, Hong
Mineishi, Shin
Claxton, David
Zhu, Junjia
Zhao, Chenchen
Jia, Bei
Ehmann, W. Christopher
Rybka, Witold B.
Naik, Seema
Songdej, Natthapol
Drabick, Joseph J.
Hohl, Raymond J.
Abstract:
Is Part Of:: American journal of hematology. Volume 96:Issue 2(2021)
Journal:: American journal of hematology
Issue:: Volume 96:Issue 2(2021)
Issue Display:: Volume 96, Issue 2 (2021)
Year:: 2021
Volume:: 96
Issue:: 2
Issue Sort Value:: 2021-0096-0002-0000
Page Start:: E46
Page End:: E50
Publication Date:: 2020-11-23
Subjects:: AML -- avelumab -- decitabine -- PD‐1 -- T cell exhaustion
Hematology -- Periodicals
616.15
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/ajh.26043 ↗
Languages:: English
ISSNs:: 0361-8609
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0824.800000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24656.xml